• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Breast cancer chemoprevention may reduce mortality in lobular carcinoma-in-situ

byMonica ParksandDavid Wang
October 3, 2015
in Obstetrics, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a prospective cohort study of over 1000 patients with lobular carcinoma-in-situ, the use of a chemopreventative agent was associated with a significantly reduced risk of invasive breast cancer.

2. Age of diagnosis and family history were not found to predict risk for breast cancer in this cohort.

Evidence Rating Level: 2 (Good)           

Study Rundown: Lobular carcinoma-in-situ (LCIS) is a rare, non-invasive feature found on breast biopsy that has been associated with an increased risk for invasive breast cancer. The current management option for this diagnosis may range from observation with or without chemoprevention (aromatase inhibitor or selective estrogen receptor modulators) to bilateral prophylactic mastectomies. The purpose of this large prospective cohort study was to examine the long-term outcomes for patients with LCIS as well as to identify clinicopathologic risk factors for invasive breast cancer in this cohort.

The study prospectively followed over 1000 patients diagnosed with LCIS that were managed with either surveillance (with or without chemoprevention) or bilateral prophylactic surgery. At the conclusion of the trial, the annual incidence of breast cancer in this population was found to be 2% per year, with a cumulative 15-year risk similar to previous reported studies. Furthermore, the use of chemoprevention was associated with a significant reduced risk of cancer. Interestingly, age of diagnosis and family history of breast cancer did not demonstrate significant association for invasive breast cancer. The results of this study support the use of chemopreventative agents in the management of patients with LCIS. This is the largest prospective cohort to analyze the long-term prognosis of patients with LCIS. However, the study is limited by the observational design, which could not account of all confounding variables. Nevertheless, these findings may assist with the counseling as well as short- and long-term management of patients with newly diagnosed LCIS.

Click to read the study in JCO

RELATED REPORTS

Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

#VisualAbstract Lack of sentinel-lymph node biopsy does not alter survival in early invasive breast cancer

Relevant Reading: Risk factors for breast cancer in women with proliferative breast disease

In-Depth [prospective cohort]: This was a large, single center, prospective cohort study of women diagnosed with lobular carcinoma in-situ (LCIS) between 1980 and 2009. A total of 1060 patients were included. All patients underwent surgical excision at the time of LCIS to rule out synchronous malignancy. 78% of patients underwent surveillance only, 17% of patients underwent surveillance with chemoprevention and 5% of patients underwent bilateral prophylactic mastectomy. After a mean follow-up of 81 months, the annual cancer development rate in this cohort was found to be at 2% per year with a cumulative incidence of 26% at 15 years. Age of LCIS diagnosis, menopausal status, family history, bilateral LCIS, BIRADS breast density, and need for subsequent biopsies were not associated with subsequent cancer diagnosis. The use of chemoprevention was associated with decrease in the incidence of invasive breast cancer (HR: 0.27; 95% CI: 0.15-0.5; p < 0.001).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: Breast Cancerchemoprevention
Previous Post

Small molecule drug targets Clostridium difficile toxins [PreClinical]

Next Post

Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants

RelatedReports

One-year of Herceptin preferable to two-year regimen
Oncology

Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

April 11, 2025
3D mammography (tomosynthesis) enhances accuracy of breast cancer screening
Chronic Disease

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

April 2, 2025
#VisualAbstract Lack of sentinel-lymph node biopsy does not alter survival in early invasive breast cancer
StudyGraphics

#VisualAbstract Lack of sentinel-lymph node biopsy does not alter survival in early invasive breast cancer

March 27, 2025
Exercise associated with decreased breast cancer risk
Oncology

Lack of sentinel-lymph node biopsy does not alter survival in early invasive breast cancer

March 18, 2025
Next Post
Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants

Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants

FIGO score ≥13 associated with early gestational trophoblastic disease death

FIGO score ≥13 associated with early gestational trophoblastic disease death

Intrapartum antibiotics associated with altered infant gut microbiome

Intrapartum antibiotics associated with altered infant gut microbiome

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Fecal microbiota transplantation may be more effective than vancomycin in treating primary C. difficile infection
  • Frailty scores alone may be poor predictors of intensive care admission or hospital stay duration
  • Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.